JPS6344581A - Substance yl-0358m-a and production thereof - Google Patents
Substance yl-0358m-a and production thereofInfo
- Publication number
- JPS6344581A JPS6344581A JP18911486A JP18911486A JPS6344581A JP S6344581 A JPS6344581 A JP S6344581A JP 18911486 A JP18911486 A JP 18911486A JP 18911486 A JP18911486 A JP 18911486A JP S6344581 A JPS6344581 A JP S6344581A
- Authority
- JP
- Japan
- Prior art keywords
- substance
- culture
- culture medium
- strain
- cultivation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- YYNGBCGFVNIEML-GLZRVVIGSA-N hatomamicin Chemical compound C\1=CC2=NCCC3OC32C/1=C/C(/C)=C/C(C(O)CC)OC1CCC(O)C(C)O1 YYNGBCGFVNIEML-GLZRVVIGSA-N 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 4
- 241000187560 Saccharopolyspora Species 0.000 claims abstract 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 7
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052799 carbon Inorganic materials 0.000 abstract description 3
- 230000001472 cytotoxic effect Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 241000192125 Firmicutes Species 0.000 abstract description 2
- 239000002246 antineoplastic agent Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 235000013372 meat Nutrition 0.000 abstract description 2
- 229910052751 metal Inorganic materials 0.000 abstract description 2
- 239000002184 metal Substances 0.000 abstract description 2
- 150000003839 salts Chemical class 0.000 abstract description 2
- 239000001963 growth medium Substances 0.000 abstract 3
- -1 etc. Chemical compound 0.000 abstract 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000012531 culture fluid Substances 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 229920001817 Agar Polymers 0.000 description 16
- 239000008272 agar Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 5
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 1
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- KYNFOMQIXZUKRK-UHFFFAOYSA-N 2,2'-dithiodiethanol Chemical compound OCCSSCCO KYNFOMQIXZUKRK-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000002447 crystallographic data Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 1
- 229940073769 methyl oleate Drugs 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、医薬、殊て抗腫瘍剤および抗菌剤として有用
なYL−0358M−A物質および発酵法による該物質
の製造法に関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a substance YL-0358M-A useful as a medicine, particularly an antitumor agent and an antibacterial agent, and a method for producing the substance by fermentation.
(発明が解決しようとする問題点、解決するための手段
)
本発明に係るYL−0358M−A物質は、つぎの化学
構造式並びπ理化学的性状によって特定される新規化合
物である。(Problems to be solved by the invention, means for solving them) The substance YL-0358M-A according to the present invention is a novel compound specified by the following chemical structural formula and π physical and chemical properties.
化学構造式:
%式%:
(1)紫外線吸収スペクトル:メタノール中での紫外線
吸収スペクトルを第1図に示す。Chemical structural formula: % Formula %: (1) Ultraviolet absorption spectrum: The ultraviolet absorption spectrum in methanol is shown in FIG.
(2)赤外線吸収スペクトル:臭化カリウム錠剤法によ
桑
る赤外線板スペクトルを第2図に示す。(2) Infrared absorption spectrum: Figure 2 shows an infrared plate spectrum obtained by the potassium bromide tablet method.
(31水素核磁気共鳴スペクトル;重クロロホルム中で
の500MHzのIH核磁気共鳴スペクトルを第3図に
示す。(31 Hydrogen nuclear magnetic resonance spectrum; 500 MHz IH nuclear magnetic resonance spectrum in deuterated chloroform is shown in FIG. 3.
(4)炭素−13−核磁気共鳴スベクトル: 重クロロ
ホルム中での125MHzの13c核磁気共鳴スペクト
ルを第4図に示す。(4) Carbon-13-Nuclear Magnetic Resonance Spectrum: The 125 MHz 13c nuclear magnetic resonance spectrum in deuterated chloroform is shown in FIG.
(5)質量分析: FAB−MSに於て390 (MH
” )及び412(M+ Na” )にシグナルが検出
される。(5) Mass spectrometry: 390 (MH
) and 412 (M+ Na”).
(6)分子量 = 389
(7)分子式 : C22H31N05(8) 比
旋光度:[α]^+88°(c’=1.メタノール)(
9)融点:93°C
αQ 外 観 : 白色結晶
+Il+ 塩基性・中性・酸性の区別:塩基性物質f
i2 溶解性 : メタノール、エタノール、アセト
ン。(6) Molecular weight = 389 (7) Molecular formula: C22H31N05 (8) Specific rotation: [α]^+88° (c' = 1. methanol) (
9) Melting point: 93°C αQ Appearance: White crystal + Il+ Distinction between basic, neutral, and acidic: Basic substance f
i2 Solubility: methanol, ethanol, acetone.
酢酸エチルおよびクロロホルムに可溶
03 薄層クロマトグラフィーのRf値: シリカゲ
ル60 F254(メルク社製)を使用。検出は[JV
2541m6表1
aa X線回折
アセトニトリル溶液よりX線解析に適する結晶を得た。Soluble in ethyl acetate and chloroform 03 Rf value of thin layer chromatography: Silica gel 60 F254 (manufactured by Merck & Co., Ltd.) was used. Detection is [JV
2541m6 Table 1 aa X-ray diffraction Crystals suitable for X-ray analysis were obtained from the acetonitrile solution.
結晶学的データーを以下に示す。 C22H31NO5
・2 H2O,Mr =−425,52,単斜晶系、空
間群C2,a=22.70f11. b = 9.51
8(61,’c = 10.786(6)X、β=90
.51(51’、 z = 4. dc= 1.21
g/am3゜線源としてCnKa(λ= 1.5418
4 A )線を用℃・、理学電機製AFc5R型4軸自
動回折計により1強度ゼロの反射40個を含む1982
個(2θ<125°)の反射強度を測定した。Crystallographic data are shown below. C22H31NO5
・2 H2O, Mr = -425,52, monoclinic system, space group C2, a = 22.70f11. b = 9.51
8(61,'c = 10.786(6)X, β=90
.. 51 (51', z = 4. dc = 1.21
CnKa (λ = 1.5418
4A) 1982, including 40 reflections with one intensity of zero, using a 4-axis automatic diffractometer AFc5R manufactured by Rigaku.
(2θ<125°) reflection intensities were measured.
構造は直接法とフーリエ合成法によって解き、精密化は
対角近似最小二乗法により行なった。各原子の帰属は電
子密度分布図中のピークの高さ、温度等て基づいて行な
った。水素原子は、差フーリエ法で得た電子密度分布図
において見い出し、精密化に含めた。最終の信頼度因子
はIFOI>3σの1830個の反射につ(・て、4.
1%であった。The structure was solved using the direct method and the Fourier synthesis method, and the refinement was performed using the diagonal least squares method. Attribution of each atom was made based on the height of the peak in the electron density distribution map, temperature, etc. Hydrogen atoms were found in the electron density distribution map obtained by the difference Fourier method and included in the refinement. The final reliability factor is 4.0 for the 1830 reflections with IFOI > 3σ.
It was 1%.
YL−0358M−Aの非水素原子の座標を表2に示す
。Table 2 shows the coordinates of non-hydrogen atoms in YL-0358M-A.
表2
表中Bの値は非等方性温度因子より計算された等価温度
因子である; B=8 x” (ut + ut +
03 )、/3.ここで’l1u21u3は平均二乗
偏位マ) リツクスUの主成分環である。く〉内の値は
異方度であり、(Σ(B8 K2Ui )2/ 3 )
で定義される。また、()内の値は標準偏差である
。Table 2 The value of B in the table is the equivalent temperature factor calculated from the anisotropic temperature factor; B=8 x” (ut + ut +
03), /3. Here 'l1u21u3 is the principal component ring of the mean square deviation matrix U. The value inside is the anisotropy, (Σ(B8 K2Ui )2/3)
Defined by Furthermore, the values in parentheses are standard deviations.
(発明の効果)
YL−0358M−A物質は各種細菌株にグラム陽性菌
に対し抗菌作用を示すと共に、各種腫瘍細胞圧動し、細
胞障害作用を有している。つぎしでこれらの作用を測定
方法と共て示す。(Effects of the Invention) The substance YL-0358M-A exhibits an antibacterial effect against various bacterial strains and gram-positive bacteria, and also has a cytotoxic effect by compressing various tumor cells. These effects are shown below along with measurement methods.
(11抗菌作用
実験方法
YL−0358M−A物質にメタノールを加え1 、O
OOμg/mlの溶液を作る。8mm径の抗菌活性測定
用の薄手のペーパーディスク(東洋製作新製)にこの溶
液をしみ込ませ、余分な液を除いたのち各珊被検菌にて
ペーノく−ディスク・アッセイを行なった。被検菌は3
7℃で16時間培養を行ない生じる生育阻止円径(mm
)を測定。(11 Antibacterial effect experimental method Add methanol to YL-0358M-A substance, add O
Make a solution of OOμg/ml. This solution was impregnated into a thin paper disk (manufactured by Toyo Seisaku Shin) with a diameter of 8 mm for antibacterial activity measurement, and after removing the excess liquid, Penoku-disk assay was performed on each coral test bacteria. The test bacteria are 3
Growth inhibition zone diameter (mm) after culturing at 7°C for 16 hours
) is measured.
結果: 表3
A:ミューラー・ヒントン寒天培地(栄研製)B ニハ
ード・インフュージョン寒天培地(栄研製)(2)腫瘍
細胞を用いる試験管内細胞障害作用方法:
I X 105cells/mZに調整したL 121
01)(establishedcell 1ine
) r P3882)(Primary cultur
ed cell )の各細胞浮遊液(cell 5us
pension ) 1 mlにメタノールで溶解した
各濃度のYL−0358M−A物質4μtを加え、37
℃でCO2inc’bator中で3日間培養後トリバ
ンプルー染色法により生存細胞を計数した。Results: Table 3 A: Mueller-Hinton agar medium (manufactured by Eiken) B Nihard infusion agar medium (manufactured by Eiken) (2) In vitro cytotoxicity method using tumor cells: L 121 adjusted to I X 105 cells/mZ
01) (establishedcell 1ine
) r P3882) (Primary culture
each cell suspension (cell 5us
Pension) Add 4 μt of YL-0358M-A substance of each concentration dissolved in methanol to 1 ml, and
After culturing for 3 days in a CO2 inc'bator at °C, viable cells were counted by Trivan blue staining.
細胞障害活性(IC50値)は薬剤無添加の細胞数を対
照として各濃度での細胞増殖抑制率を算出し。Cytotoxic activity (IC50 value) was determined by calculating the cell growth inhibition rate at each concentration using the number of cells without addition of the drug as a control.
グラフ上にプロットして求めた。It was calculated by plotting it on a graph.
使用した培地
1) RPMI−1640+10% 新生中血清2)
RPMI−1640+ 5% 牛血清+ 5μM
2−ヒドロキシエチル
ジスルフィド
(製造法)
YL −0358M −A物省は、サツカロポリスポラ
属に属するYL −0358M −A物質生産菌を培養
し。Medium used 1) RPMI-1640+10% Neonatal serum 2)
RPMI-1640+ 5% bovine serum + 5μM
2-Hydroxyethyl disulfide (manufacturing method) YL-0358M-A Ministry of Finance cultivated YL-0358M-A substance-producing bacteria belonging to the genus Satucharopolyspora.
培養物からYL −0358M −A物質を採取するこ
とにより製造することができる。It can be produced by collecting YL-0358M-A substance from a culture.
この製造法で使用するYL −0358M −A物質生
産菌の一例としては、沖縄県鳩間島の土壌より分離した
サツカロポリスポラ グリセオプルプレア(5acch
aropolyspora griseopurpur
ea #=哄)YL −0358M株(微工研菌寄第8
862号)を挙げることかできる。この菌株の菌学的性
状を以下に記す。An example of YL-0358M-A substance-producing bacteria used in this production method is Satsucalopolyspora griseopurpurea (5acch), which was isolated from the soil of Hatoma Island, Okinawa Prefecture.
allopolyspora griseopurpur
ea #=哄) YL-0358M strain (Feikoken Bacterial Collection No. 8
862). The mycological properties of this strain are described below.
l、形態
本菌株は、各種寒天培地上で比較的長く分枝した基生菌
糸を形成し、そこから分枝した短かい胞子柄の末端には
2通常1個の基生胞子が観察される。基生菌糸はチロシ
ン寒天培地、イースト麦芽寒天培地、スターチ無機塩寒
天培地上で灰味紫または紫味灰色を呈す。l. Morphology This strain forms relatively long, branched basal hyphae on various agar media, and one basal spore is usually observed at the end of the short sporophyte that branches from the basal hyphae. . The basal hyphae exhibit a gray-purple or purplish-gray color on tyrosine agar, yeast malt agar, and starch inorganic salt agar.
培養が進むと基生菌糸は桿菌状に断裂する。As the culture progresses, the basal hyphae rupture into rod-like shapes.
グリセリン・アスパラギン寒天培地、チロシン寒天培地
上などで形成される気菌糸は、白(・粉状で、その先端
には胞子鎖が認められる。Aerial hyphae formed on glycerin/asparagine agar medium, tyrosine agar medium, etc. are white (powder-like), and spore chains are observed at the tips.
電子顕微鏡下では胞子はほぼ長だ円形で04μm −0
,6pm X O,7ttm 〜0.9 μmの大きさ
で、成熟した場合10個以上の連鎖が観察される。また
胞子表面は毛様構造をもつさやKおおわれて(・る。Under an electron microscope, the spores are approximately oval in shape with a diameter of 04 μm −0.
,6pm In addition, the spore surface is covered with a sheath K that has a hair-like structure.
2、各種寒天培地上の性状
各種寒天培地上の性状は、以下に示すとおりである。特
に記載しな(・かぎり、28°Cで21日間培養し、常
法に従って観察したものである。色調の記載については
色の標準(日本色彩研究所)によった。2. Properties on various agar media Properties on various agar media are as shown below. Unless otherwise specified, the samples were cultured at 28°C for 21 days and observed according to conventional methods. Color descriptions were based on color standards (Japan Color Research Institute).
表4
(注)G:生育及び集落表面の菌叢色 A:気菌糸の着
生及びその色相R:裏面の色相 S:可溶性色素
3、生理的性質
表5
(注)生育温度は各温度(5,10,15,20,25
,28,30゜33、37.40.45.50°C)で
、7−21日までの観察結果、ミルクに対する作用は3
7℃で3−21日までの観察結果。それ以外は、特に指
摘のなし・かぎり、28°Cで2週間後の観察結果を示
す。Table 4 (Note) G: Growth and bacterial flora color on the colony surface A: Epiphytion of aerial mycelium and its hue R: Hue on the back side S: Soluble pigment 3, physiological properties Table 5 (Note) The growth temperature is at each temperature ( 5, 10, 15, 20, 25
, 28, 30° 33, 37. 40. 45. 50°C), and as a result of observation from 7 to 21 days, the effect on milk was 3.
Observation results from 3 to 21 days at 7°C. Otherwise, unless otherwise specified, the results are shown after 2 weeks at 28°C.
4、炭素源の資化性
(プリドハム・ゴドリープ寒天培地、28°C培養)表
6
5、細胞壁及び全細胞加水分解抽出物などの分析LEC
HVALIERらの方法(LECHVALIER,MP
。4. Assimilation of carbon sources (Pridham-Godliep agar medium, 28°C culture) Table 6 5. Analysis LEC of cell walls and whole cell hydrolyzed extracts, etc.
The method of HVALIER et al. (LECHVALIER, MP
.
et al ; PP277 283 in DIET
Z、 Aet al ed、。et al; PP277 283 in DIET
Z, Aet al ed,.
DAP )が検出された。また、糖成分とじてアラビノ
ースとガラクトースを含むことが認められたが、ミコー
ル酸は検出されなかった。DAP) was detected. In addition, it was confirmed that the sugar components contained arabinose and galactose, but no mycolic acid was detected.
以上の性状を要約すると、 YL−0358Maは、基
生菌糸がチロシン寒天培地上などで灰味紫〜紫味灰色を
呈し、培養が進むと桿菌状に断裂し、基生菌糸から分枝
した短かい胞子柄の末端には通常1個の基生胞子が観察
される。白色粉状の気菌糸は先端に10個以上の胞子鎖
を形成し、胞子表面は毛様構造をもつさやにおおわれて
いる。グリセリン・アスパラギン寒天培地、スターチ・
無機塩寒天培地。To summarize the above properties, the basal hyphae of YL-0358Ma exhibit a grayish-purple to purplish-gray color on tyrosine agar medium, etc., and as the culture progresses, they rupture into rod-like shapes, and short hyphae branch from the basal hyphae. A single basal spore is usually observed at the end of the sporophore. The white powdery aerial hyphae form ten or more spore chains at the tip, and the spore surface is covered with a sheath with a hair-like structure. Glycerin/asparagine agar medium, starch/
Inorganic salt agar medium.
イースト麦芽寒天培地などで茶色の可溶性色素を産生ず
る。細胞壁の分析で、特徴的アミノ酸としてメソ−ジア
ミノピメリン酸(meso−=DAP)が、糖成分とし
てアラビノース、ガラクトースが検出された。Produces a brown soluble pigment on yeast malt agar media, etc. Analysis of the cell wall detected meso-diaminopimelic acid (meso-=DAP) as a characteristic amino acid, and arabinose and galactose as sugar components.
これらの結果より、 YL −’0358 M株はサツ
カロポリスポラ(5accharopolyspora
)属(J、Laceys。From these results, the YL-'0358 M strain was found to be 5accharopolyspora.
) genus (J, Laceys.
ジャーナルーオブ・ゼネラルマイクロバイオロジー。Journal of General Microbiology.
88巻、75頁* 1975年)に属する菌株と考え
ろ又 タ
わ、サツカロポリスポラ ヒル輿≠(S、hirsut
a )KCCA−0170株と実際に比較し、また参考
のたり
めサツカロポリスポラ ヒル郷 サブエスビーコーベ工
/シス(S、hirsuta 5Wbsp、kober
+sis ) KC−6606株と文献上で比較した(
T、 Deushi et a+ジャーナル虐オブ・
アンティバイオティクス、32巻、173頁、 197
8年)。その結果を下表71で記す。Volume 88, p. 75*1975)
a) Actual comparison with KCCA-0170 strain, and also for reference.
+sis) Compared with the KC-6606 strain in the literature (
T, Deushi et a+ Journal of Massacres
Antibiotics, vol. 32, p. 173, 197
8 years). The results are shown in Table 71 below.
表に示すようKYL−0358M株は、 KCCA−0
170株、 KC−6606株と一致する点が多く認め
られるものの、生育温度範囲が低〜・こと、及び灰汁紫
色を呈する。発育の色調において両菌株と大きく異なっ
ている。また、メラニン様色素の生成が弱陽性であるこ
と、牛乳の凝固が陽性であることなど生理的性質におい
て既知菌種と相違がみられる。以上のことがら YL
−0358M株はサツカロポリスポラ属に属する既知の
菌種とは各種の性状が異なっているため、サツカロポリ
スボラ属の新種と考えられる。そこで、特徴的な発育の
色に基づきサツカロポリスポラ グリセオプルプレア
ニス・ピー ノブ(S accharopolyspo
ragriaeopurpurea 5uzuKt、
NACAI、 and 5AITOHsp、nov )
と命名し、タイプストレインとしてYL −0358M
株が工業技術院微生物工業技術研究所に受託番号微工研
菌寄第8862号として受託されている。As shown in the table, the KYL-0358M strain is KCCA-0
Although there are many similarities with strain 170 and KC-6606, the growth temperature range is low to low and it exhibits a lye purple color. The color tone of growth is significantly different from both strains. In addition, there are differences from known bacterial species in physiological properties, such as weakly positive production of melanin-like pigments and positive coagulation of milk. The above matters YL
The -0358M strain is considered to be a new species of the genus Satucharopolispora because its characteristics are different from known bacterial species belonging to the genus Satucharopolispora. Therefore, based on the characteristic growth color, Satucharopolyspora griseopurpurea
Varnish pea knob (S accharopolyspo)
ragriaeopurpurea 5uzuKt,
NACAI, and 5AITOHsp, nov)
YL-0358M as the type strain.
The strain has been entrusted to the Institute of Microbial Technology, Agency of Industrial Science and Technology under accession number 8862.
(培養法)
本発明の製造法で用(・られる微生物は天然の土壌より
分離して取得したものであるが、前記微生物工業技術研
究所に寄託した菌株の凍結乾燥品を復元することによっ
て容易に取得することができる。この微生物は1人工的
にまた自然に変異をおこしやすいが9本発明のいう Y
L −0358M株は天然から分離された放線菌、8.
るいはこれを紫外線、X線、化学薬剤などで人工的に変
異させた菌株及びそれらの自然変異株をも包含するもの
である。YL −0358M −A物質生産菌の培養は
一般微生物の培養方法に準じておこなわれるが通常は液
体培地による深部培養法が有利である。培養に用−・ら
れる培地としては。(Culture method) The microorganisms used in the production method of the present invention are obtained by isolation from natural soil, but they can be easily obtained by restoring the freeze-dried product of the strain deposited with the Microbial Technology Research Institute. This microorganism can be easily mutated either artificially or naturally.
Strain L-0358M is an actinomycete isolated from nature, 8.
It also includes strains that have been artificially mutated using ultraviolet rays, X-rays, chemical agents, etc., as well as natural mutant strains thereof. Cultivation of the YL-0358M-A substance-producing bacteria is carried out according to the cultivation method of general microorganisms, but the deep culture method using a liquid medium is usually advantageous. As a medium used for culture.
該生産菌が利用する栄養源を含有する培地であればよい
。すなわち合成培地、半合成培地ある〜・は天然培地が
用いられ、培地の組成は、たとえば炭素源としては D
−キシロース、グルコース、D−フラクトース、L−ラ
ムノース、マンニトール、グリセリン、デキストリン、
殿粉、植物油などが、窒素源としては肉エキス、ペプト
ン。Any medium may be used as long as it contains a nutrient source used by the producing bacteria. In other words, a synthetic medium, a semi-synthetic medium, and a natural medium are used, and the composition of the medium is, for example, D as a carbon source.
-xylose, glucose, D-fructose, L-rhamnose, mannitol, glycerin, dextrin,
Starch, vegetable oil, etc. are used as nitrogen sources, and meat extract and peptone are used as nitrogen sources.
グルテンミール、綿実粕、大豆粉、落花生粉。Gluten meal, cottonseed meal, soybean flour, peanut flour.
魚粉、コーンスチープリカー、乾燥酵母、酵母エキス、
硫酸アンモニウム、硝酸アンモニウム。Fishmeal, cornsteep liquor, dried yeast, yeast extract,
Ammonium sulfate, ammonium nitrate.
尿素その他の有機または無機の窒素源が用いられる。ま
た金属塩としてNA、 K、 CIL、 Zn、 Fe
などの硫酸塩、硝酸塩、塩化物、炭酸塩、燐酸塩などが
必要に応じて添加される。さらπ必要に応じて、メチオ
ニン、システィン、シスチン、オレイン酸メチル、ラー
ド油、シリコン油、界面活性剤などの抗生物質生成促進
物質又は消泡剤が適宜使用される。Urea and other organic or inorganic nitrogen sources are used. Also, as metal salts NA, K, CIL, Zn, Fe
Sulfates, nitrates, chlorides, carbonates, phosphates, etc. are added as necessary. Furthermore, if necessary, antibiotic production accelerators or antifoaming agents such as methionine, cysteine, cystine, methyl oleate, lard oil, silicone oil, and surfactants are used.
培養条件としては好気的条件下に培養するのが一般的に
有利そ、培養温度は約15〜37℃の範囲が望ましく、
好ましくは約28℃附近が用t・られ、培地のpHは約
5〜10.好ましくは約6〜8の範囲に保持すると好結
果が得られる。As for the culture conditions, it is generally advantageous to culture under aerobic conditions, and the culture temperature is preferably in the range of about 15 to 37°C.
Preferably, the temperature is around 28°C, and the pH of the medium is around 5-10. Good results are obtained by keeping it preferably in the range of about 6-8.
培養期間は培地の組成、温度などによって変動するが、
一般に1〜5日程度でよく、培養終了時に目的物質が選
択的に蓄積される。The culture period varies depending on the composition of the medium, temperature, etc.
Generally, it takes about 1 to 5 days, and the target substance is selectively accumulated at the end of the culture.
培養物より本発明の目的物を単離採取するには通常の微
生物の培養物より抗生物質を単離する方法が適用される
。YM −0358M −A物質は培養液中に含有され
るので、遠心分離またはr過により菌体を除去した後、
濾過液から有効物質の抽出をおこなう。すなわち適当な
溶剤に対する溶解性および溶解度の差、溶液からの析出
性および析出速度の差9種々の吸着剤に対する吸着親和
性の差、2種の液相間における分配の差などを利用・す
る一般の抗生物質の製造に用いられる手段によって1分
離、採取、精製される。In order to isolate and collect the object of the present invention from a culture, a conventional method for isolating antibiotics from a microbial culture is applied. Since the YM-0358M-A substance is contained in the culture solution, after removing the bacterial cells by centrifugation or filtration,
The active substance is extracted from the filtrate. In other words, the general method utilizes differences in solubility and solubility in appropriate solvents, differences in precipitability from solutions and precipitation rates9, differences in adsorption affinity for various adsorbents, and differences in distribution between two liquid phases. 1. Separation, collection, and purification by means used in the production of antibiotics.
この方法は必要に応じて単独で用いられ、ある(・は任
意の順序に組合せ、また反覆して適用できる。つぎに、
実施例により本発明をさらに詳細に説明する。This method can be used alone as needed, and can be applied in any combination or repetition in any order.
The present invention will be explained in more detail with reference to Examples.
実施例
白色デキストリン2.0%、グルコース0.5%、ポリ
ペプトン0.5%、酵母エキス0.5%、コーン・ステ
ィーフ骨リカー05%、)゛レイン・ハート・インフュ
ージョン0.52%及び炭酸カルシウム0.2%を含む
培地(pH8,0)を作製し、これを500 ml三角
フラスコに各60m1ずつ分注し、120°Cで20分
間滅菌したものに、 YS寒天培地上に生育させたサン
カロボリスポラ・グリセオプルプレアの菌糸をかき取っ
て接種し、28°Cで48時間振盪培養を行ない種培養
液とする。つぎにポテト・スターチ3.0%、小麦胚芽
1.0%、コプラ・ミール1.0%、フェザ−・ミール
0.2%及び炭酸カルシウム0.15%を含む培地(p
f(7,0)を81作製し、これを500 ml三角フ
ラスコに各60m1ずつ分注し、120℃で20分間滅
菌したものに種培養液を3.0%の割合で植菌した。2
8℃で72時間振盪培養を続けるとバチルス・サブチリ
スATCC6633株に対する抗菌活性は最大となる。Example: 2.0% white dextrin, 0.5% glucose, 0.5% polypeptone, 0.5% yeast extract, 05% corn steeple bone liquor, 0.52% rain heart infusion and carbonic acid. A medium containing 0.2% calcium (pH 8.0) was prepared, and 60 ml of this was dispensed into 500 ml Erlenmeyer flasks, sterilized at 120°C for 20 minutes, and then grown on YS agar medium. The mycelia of Sancaloborispora griseopurpurea were scraped and inoculated, and cultured with shaking at 28°C for 48 hours to prepare a seed culture. Next, a medium (p
81 f(7,0) were prepared, and 60 ml of each was dispensed into 500 ml Erlenmeyer flasks, which were sterilized at 120° C. for 20 minutes and inoculated with a seed culture solution at a rate of 3.0%. 2
When the shaking culture is continued for 72 hours at 8°C, the antibacterial activity against Bacillus subtilis ATCC6633 strain reaches its maximum.
このようにして得られた培養液にラジオライ) #60
0 (昭和化学工業製)を加えて攪拌の後、濾過すると
P液6tが得られる。このr液に0.1規定水酸化す)
リウム溶液を加えてpH8,5に調整した後、 61
の酢酸エチルを加えてよく攪拌する。酢酸エチル属を分
離した後。Radiolye #60 is added to the culture solution thus obtained.
0 (manufactured by Showa Kagaku Kogyo), stirred, and filtered to obtain 6 tons of P liquid. Add 0.1N hydroxide to this R liquid)
After adjusting the pH to 8.5 by adding a solution of 61
of ethyl acetate and stir well. After separating the ethyl acetate group.
これにpH3,0に調整した塩酸水800 mlを加え
よく攪拌する。塩酸水層を分離した後2重曹を添加して
pH8,5に調整した後、酢酸エチル1tを加えてよく
攪拌する。酢酸エチル層を分離して、これに無水硫酸ナ
トリウムを加えて脱水する。つぎに無水硫酸ナトリウム
をP別した後、酢酸エチル層を減圧濃縮すると淡黄色物
質が460111g得られる。得られた淡黄色物146
0■を少量のクロロホルムに溶解させ、ワコー・ゲルC
−200(和光紬薬製) 10gをクロロホルムに充填
したカラムに乗せ、りa口ホルム:メタノール(50:
1)を展開溶剤とするカラム・クロマトグラフィーを遮
光条件下で行な℃・バチルス・サブチリスATCC66
33株に抗菌活性を示す画分を集めて減圧濃縮すると微
黄色物質が223 mg得られる。得られた微黄色物1
223 rllgを酢酸エチル4mtK溶解させ遮光条
件下で5°Cに放置すると結晶が生成する。つぎに生成
した結晶をP取して減圧下乾燥すると純粋なYL−03
58M−A物質が白色結晶として73mg得られた。Add 800 ml of hydrochloric acid water adjusted to pH 3.0 to this and stir well. After separating the hydrochloric acid aqueous layer, dibasic soda was added to adjust the pH to 8.5, and then 1 t of ethyl acetate was added and stirred well. The ethyl acetate layer is separated and dehydrated by adding anhydrous sodium sulfate. Next, after separating the anhydrous sodium sulfate with P, the ethyl acetate layer was concentrated under reduced pressure to obtain 460,111 g of a pale yellow substance. Obtained pale yellow substance 146
0■ in a small amount of chloroform, Wako Gel C
-200 (manufactured by Wako Tsumugi Pharmaceutical Co., Ltd.) 10g was placed on a column filled with chloroform, and then aliquots of form:methanol (50:
Column chromatography using 1) as a developing solvent was performed under light-shielded conditions at ℃ Bacillus subtilis ATCC66.
Fractions showing antibacterial activity against 33 strains were collected and concentrated under reduced pressure to obtain 223 mg of a slightly yellow substance. Obtained slightly yellow substance 1
When 223 rllg is dissolved in 4mtK ethyl acetate and left at 5°C under light-shielded conditions, crystals are formed. Next, P is removed from the generated crystals and dried under reduced pressure to obtain pure YL-03.
73 mg of 58M-A substance was obtained as white crystals.
YL−0358M−A物質の化学構造式および理化学的
性状は、前述の通りである。The chemical structural formula and physical and chemical properties of the substance YL-0358M-A are as described above.
第1図は、 YL−0358M−A物質の紫外線吸収ス
ペクトルを示す。
第2図は、 YL−0358M−A物質の赤外線吸収ス
ペクトルを示す。
第3図は、 YL−0358M−A物質の1)(核磁気
共鳴スペクトルを示す。
第4図は、 YL−0358M−A物質の+3H核磁気
共鳴スペクトルを示す。
第1図
第2図
第3図
第4図
手続補正書
1、事件の表示
昭和61年特許願第189114号
2、発明の名称
YL−0358M−A物質およびその製造法3、補正を
する者
事件との関係 特許出願人
住 所 東京都中央区日本橋本町2丁目5番地1名
称(467)山之内製薬株式会社
代表者森岡茂夫
4、代理人
住 所 東京都板橋区小豆沢1丁目1番8号山之内
製薬株式会社 特許部内 2.漏4氏名 (90
94)弁理士藤野清也:、。
5、補正命令の日付自発
7、補正の内容
C」にそれぞれ訂正する。
(2)同第11頁第5行「表4」を「表5」に訂正する
。
(3)同第13頁第2行r表5Jを「表6」に、第12
行「硝酸の還元作用」を「硝酸塩の還元作用」に訂正す
る。
(4)同第14頁第3行「表6」を1表7」に訂正する
。
(5)同第16頁第1〜2行「考えられ、サツカロポリ
スボラ・・・」を「考えられた。 そこで、サツカロポ
リスポラ・・・」に訂正する。
(6)同第16頁第8行及び第10行「表7」を「表8
」に訂正する。
(7)同第17行下から3行「呈する。発育の」を「呈
する発育の」に訂正する。FIG. 1 shows the ultraviolet absorption spectrum of the YL-0358M-A substance. FIG. 2 shows the infrared absorption spectrum of the YL-0358M-A material. Figure 3 shows the nuclear magnetic resonance spectrum of the YL-0358M-A substance. Figure 4 shows the +3H nuclear magnetic resonance spectrum of the YL-0358M-A substance. Figure 1 Figure 2 Figure 3 Figure 4 Procedural amendment 1, Indication of the case 1989 Patent Application No. 189114 2, Name of the invention YL-0358M-A substance and its manufacturing method 3, Person making the amendment Relationship with the case Patent applicant address 2-5-1 Nihonbashi Honmachi, Chuo-ku, Tokyo Name (467) Yamanouchi Pharmaceutical Co., Ltd. Representative Shigeo Morioka 4 Agent address 1-1-8 Azukizawa, Itabashi-ku, Tokyo Yamanouchi Pharmaceutical Co., Ltd. Patent Department 2. Lecture 4 Name (90
94) Patent attorney Seiya Fujino:. 5. Date of amendment order 7. Contents of amendment C.” (2) On page 11, line 5, "Table 4" is corrected to "Table 5." (3) Table 5J, page 13, line 2, is changed to “Table 6”, and column 12
Correct the line ``Reducing effect of nitric acid'' to ``Reducing effect of nitrate.'' (4) On page 14, line 3, ``Table 6'' is corrected to ``Table 1, Table 7''. (5) On page 16, lines 1 and 2, "It was thought of, Satucalopolispora..." was corrected to "It was thought of. Therefore, Satucalopolispora...". (6) Change “Table 7” to “Table 8” in lines 8 and 10 of page 16.
” is corrected. (7) In the 17th line, 3 lines from the bottom, "present. development" is corrected to "present development."
Claims (3)
ロポリスポラ属に属する菌株を培養し、培養液よりYL
−0358M−A物質を採取することを特徴とするYL
−0358M−A物質の製造法。(2) Cultivate a strain belonging to the genus Saccharopolyspora that has the ability to produce YL-0358M-A substance, and extract YL from the culture solution.
YL characterized by collecting -0358M-A substance
-0358M-A Method for producing substance.
リスポラ・グリセオブルプレアYL−0358M(微工
研菌寄第8862号)である特許請求の範囲第2項記載
の製造法。(3) The production method according to claim 2, wherein the strain belonging to the genus Saccharopolyspora is Saccharopolyspora griseobulupurea YL-0358M (Feikoken Bibori No. 8862).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18911486A JPS6344581A (en) | 1986-08-11 | 1986-08-11 | Substance yl-0358m-a and production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18911486A JPS6344581A (en) | 1986-08-11 | 1986-08-11 | Substance yl-0358m-a and production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6344581A true JPS6344581A (en) | 1988-02-25 |
Family
ID=16235613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18911486A Pending JPS6344581A (en) | 1986-08-11 | 1986-08-11 | Substance yl-0358m-a and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6344581A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1100676C (en) * | 1997-08-27 | 2003-02-05 | 索尼公司 | Information recording apparatus and method |
-
1986
- 1986-08-11 JP JP18911486A patent/JPS6344581A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1100676C (en) * | 1997-08-27 | 2003-02-05 | 索尼公司 | Information recording apparatus and method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68902670T2 (en) | KS-506 CONNECTIONS AND METHOD FOR THE PRODUCTION THEREOF. | |
EP0491956A1 (en) | Reveromycin a, production thereof, and antitumor drug and fungicide | |
JPS6344581A (en) | Substance yl-0358m-a and production thereof | |
JPH03157372A (en) | Yl-01869p substance and production thereof | |
EP0314401B1 (en) | New compound wf 2015 a and b, production thereof and use thereof | |
JPS6348284A (en) | Novel antibiotic yp-02908l-a and production thereof | |
JPH0578322A (en) | New antibiotic sf2738 substance, its production and carcinostatic agent | |
JPH01168660A (en) | Yl-0710m compound and production thereof | |
KR830000617B1 (en) | Process for preparing antibiotics sf 2050 substances | |
JPS63122686A (en) | Yl-0358m-b substance and production thereof | |
JP2578486B2 (en) | New substance KS-502 | |
JPH06211615A (en) | Bu-4803t antibiotic | |
JPH0625095B2 (en) | Antibiotic SF-2415 substance and its production method | |
KR810000686B1 (en) | Process for the preparation of piperidine derivative | |
JPH0413353B2 (en) | ||
JPS5932120B2 (en) | Method for producing 9-β-D arabinofuranosyl adenine | |
JPH0446188A (en) | New antibiotic pf1032b substance and production thereof | |
CA2071655A1 (en) | Sporormiella intermedia and processes therefrom | |
JPS62275687A (en) | Yp-02259l-a and c substance and production thereof | |
JPH09100261A (en) | Antimicrobial substance be-44651 | |
JPS62132897A (en) | Physiologically active substance k-13 and production thereof | |
JPS60114194A (en) | Antibiotic yp-0583i-alpha and its preparation | |
JPS62175493A (en) | Novel antibiotic yp-02908l-a and production thereof | |
JPS6027390A (en) | Fr-900216 substance and its preparation | |
JPS60190785A (en) | Leucanicidin and its preparation |